Most Australian states and territories have adopted legal thresholds for drug trafficking, over which possession of an illicit drug is deemed ‘trafficking’ as opposed to ‘personal use’.
Prisoners are a marginalised group placing considerable costs on society. They experience very high rates of drug dependence, health problems and premature mortality. Without intervention they are highly likely to come into further health risk.
Hepatitis C virus (HCV) is highly prevalent among incarcerated people around the world, largely due to the high concentration in correctional settings of people who inject drugs.
There is little detailed information about the Australian cannabis market, including the chemical characteristics of the locally available cannabis product.
There is a growing body of research evidence demonstrating the impact of a range of pre-sentence diversion options at engaging substance misusing defendants in treatment, and reducing illicit drug use and ‘related’ offending in both Australian and British contexts.
Within both the Australian and international literature, the association between substance use and criminal activity is well established. The nature of the relationship, however, is still widely debated with no overall consensus being reached on how crime and substance use influence each other.
There is a lack of knowledge about the offending profiles of MDMA offenders and the optimal means of policing MDMA.
The current project is concerned with elucidating a little known phenomenon in retail level illicit drug markets: the supply of illicit drugs within social networks. There is very little published empirical research in this area, a fact which itself strikes a call for further research. Drug pol
The Australian National Council on Drugs (ANCD) has requested a review of the prevalence of alcohol and/or drug use problems among prisoners and the range and availability of supply, demand and harm reduction programs and services in prisons.